Alprostadil is a medication used in the management and treatment of erectile dysfunction in males and for temporary patency of ductus arteriosus in newborns with congenital heart diseases before surgical intervention. It is in the prostaglandin analog class of medications. This activity reviews the indications, action, and contraindications for alprostadil as a valuable agent in the therapy of erectile dysfunction in males and presurgical management for newborns with congenital heart diseases with ductus arteriosus dependent circulation. This activity will also highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, monitoring, relevant interactions) pertinent for members of the interprofessional team in the management of those conditions.

**Objectives:**
- Review the indications for alprostadil.
- Describe the adverse effects and contraindications of alprostadil.
- Identify the appropriate monitoring and toxicity of alprostadil.
- Summarize interprofessional team strategies for enhancing care coordination and communication to advance the management of conditions that can be treated with alprostadil and improve patient outcomes.